The following are current disclosure of outside interests for the Center for Cell and Gene Therapy investigators.
Helen Heslop, M.D.
Interest | Company |
---|---|
Equity | Allovir Marker Therapeutics Fresh Wind Biotechnologies CoRegen Inc. |
Scientific Advisory Board | Gilead Biosciences Novartis Tessa Therapeutics Marker Therapeutics Kiadis PACT Pharma Mesoblast Ankyra Therapeutics |
Research Support | Tessa Therapeutics Kuur Therapeutics |
Royalties | None |
Spouse Disclosures | None |
Other | None |
Malcolm Brenner, M.D., Ph.D.
Interest | Company |
---|---|
Equity | Allovir Marker Therapeutics Tessa Therapeutics |
Scientific Advisory Board | Tessa Therapeutics Marker Therapeutics Allogene Walking Fish Kuur Turnstone Biologics Posedia Tscan Bluebird Bio Adaptimmune Therapeutics Adintus Onkimure Triumvira Immunologics Allogene Bellicum Pharmaceuticals Memgen, LLC Brooklyn Immunotherapeutics Coya Astrazeneca Pharmaceuticals |
Research Support | None |
Royalties | Takeda Bellicum Maker Therapeutics |
Spouse Disclosures | See Cliona Rooney |
Stock | Turnstone, Bluebird Bio, Allogene, Walking Fish, AlloVir, Tessa, Tscan |
Leadership | Founder Member Maker Therapeutics |
Consulting | Memgen, Bellicum, KURR, Tessa, Turnstone, Bluebird Bio, Allogene, Walking Fish, Abintus Bio and Adaptimmune |
Other | None |
Bambi Grilley
Interest | Company |
---|---|
Equity | AlloVir, QBRegulatory LLC |
Scientific Advisory Board | |
Research Support | |
Royalties | None |
Spouse Disclosures | None |
Other | QBRegulatory Consulting, LLC provides or has provided consulting services to AlloVir, Marker Therapeutics, Tessa Therapeutics, Lokon Pharma, March Bio and Proxima Clinical Research |
Natalia Lapteva
Interest | Company |
---|---|
Equity | None |
Scientific Advisory Board | None |
Research Support | Tessa Therapeutics |
Royalties | None |
Spouse Disclosures | None |
Other | Consultant for Tessa Therapeutics |
Maksim Mamonkin Ph.D.
Interest | Company |
---|---|
Equity | March Biosciences |
Scientific Advisory Board | March Biosciences, NKILT Therapeutics |
Research Support | March Biosciences, Fate Therapeutics |
Royalties | Fate Therapeutics, Allogene, March Biosciences, Beam Therapeutics |
Consulting | Amgen, Galapagos NV, Laverock Therapeutics, Xenetic Biosciences, Allogene |
Leadership/Board of Directors | March Biosciences |
Spouse Disclosures | None |
Other | None |
Carlos Ramos
Interest | Company |
---|---|
Equity | None |
Scientific Advisory Board | Novartis |
Research Support | Tessa Therapeutics Kuur Therapeutics |
Royalties | None |
Spouse disclosures | None |
Other | None |
Cliona Rooney, Ph.D.
Interest | Company |
---|---|
Equity | Allovir Marker Therapeutics |
Scientific Advisory Board | Tessa Therapeutics Marker Therapeutics Cell Genix |
Research Support | Tessa Therapeutics |
Royalties | Takeda Marker Allovir Bellicum |
Spouse Disclosures | See Malcolm Brenner |
Other | None |
Valentina Hoyos, M.D.
Interest | Company |
---|---|
Royalties | Takeda |
Consulting | AztraZeneca |
Other | None |
Masataka Suzuki
Interest | Company |
---|---|
Research Support | Tessa Therapeutics, AstraZeneca |
Consulting | Tessa Therapeutics |
Updated April. 24, 2024